Morning Break: Flabby Tush Medicalized; Infections and Alzheimer's

Ohio State says: beware of DBS -- Dormant Butt Syndrome.

"I Wish Someone Had Told Us the Risks and Benefits of Replacing My Father's Defibrillator," writes Pamela Diaconis in JAMA Internal Medicine.

Here's a shocker: a new report suggests that the NFL was trying to "influence" the findings of a concussion study when the league gave the NIH millions to help fund the research. (The New York Times)

Is it fair that California landlords may soon be allowed to ban tenants from smoking medical marijuana in their apartments? (San Diego Reader)

Pfizer said the European Medicines Agency had agreed to remove the "black triangle" safety monitoring requirement for the stop-smoking drug varenicline (sold as Champix there, Chantix in the U.S.). The boxed warning about possible psychiatric side effects will stay, though.

Newsweek examines theories that infections trigger Alzheimer's disease.

The family of baseball great Tony Gwynn, who died in 2014 from salivary gland cancer, is suing Altria Group for "manipulating" him into a lethal smokeless tobacco addiction. (The New York Times)

What's going on at Novartis? Reuters notes that seven top execs have left in the past 5 months.

VA chief McDonald says it doesn't matter how long Vets wait for medical appointments as long as they are satisfied overall with their care. (Washington Post)

Yellow fever is poised to jump from Angola to China -- "global catastrophe" looms, warns the International Journal of Infectious Diseases.

The Anthem-Cigna insurer megamerger may be falling apart. (Reuters)

A British restaurant owner was convicted of manslaughter after serving nuts to a patron who had requested no nuts, and who then died of an allergic reaction. (The New York Times)

Being poor is expensive, which is why poor people usually stay that way, explains the PLOS Public Health blog.

Is medical residency tantamount to indentured servitude? A soon-to-be resident worries at Scientific American.

Here's a look at what it's like to climb Mt. Everest without supplemental oxygen. Which, by the way, raises the already daunting risk of dying on the mountain by about seven-fold. (Washington Post)

Bloomberg looks at what Big Pharma is doing (or not doing) about Zika virus.

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.

Let's block ads! (Why?)

Morning Break: Flabby Tush Medicalized; Infections and Alzheimer's